中年早期慢性肾脏病患者的骨折状况:CARTaGENE调查的横断面分析
该研究基于CARTaGENE人群调查进行横断面分析,纳入17608名40至69岁个体,比较早期慢性肾脏病(CKD)与非CKD者的骨折状况。结果显示,CKD 3期骨折状况患病率为14.9%,CKD 2期为10.8%,非CKD者为9.0%,但按年龄分层或调整人口学和临床参数后,CKD与非CKD个体间骨折状况患病率相似。跟骨定量超声硬度指数在CKD 3期、CKD 2期和非CKD个体中均与骨折状况相关,且血压、降压药与骨折状况的关联随CKD进展呈U形。
要点
- CKD 3期骨折状况患病率为14.9%,CKD 2期为10.8%,非CKD者为9.0%。
- 按年龄分层或调整混杂因素后,CKD与非CKD个体骨折状况患病率相似。
核心结论
- CKD 3期与骨折状况增加无关。
- 定量超声参数在伴和不伴CKD的患者中与骨折状况的关联相似。
研究设计与样本
- CARTaGENE调查的横断面分析,人群为40至69岁个体。
- CKD定义为2期估算肾小球滤过率(eGFR)60-89 ml/min/1.73 m2,3期eGFR 30-59 ml/min/1.73 m2;非CKD为eGFR大于90 ml/min/1.73 m2。
- 共纳入17608名个体,其中CKD 3期656名,CKD 2期8227名,非CKD 8725名。
- 骨折状况通过基线问卷识别,排除面部、脚趾、手和髌骨骨折;每位参与者均测量跟骨定量超声。
主要发现
- 骨折状况患病率:CKD 3期为14.9%,CKD 2期为10.8%,非CKD者为9.0%。
- 按年龄分层或调整人口学和临床参数后,CKD与非CKD个体骨折状况患病率相似。
- 血压、降压药与骨折状况的关联在整个CKD进展过程中呈U形。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Whether early chronic kidney disease (CKD) is associated with fracture in middle-aged adults is unclear. In a cross-sectional analysis of the CARTaGENE survey, we observed that early CKD was not associated with increased fracture, did not modify the association between calcaneal QUS and fracture, but modified the association between clinical, pharmacological parameters and fracture. INTRODUCTION: The association between advanced CKD and increased fracture risk is well described. However, whether early CKD is associated with increased fractures, especially in middle-aged adults, is unclear. We aimed to assess if early CKD is associated with increased fracture status and whether early CKD status modifies the association between calcaneal quantitative ultrasound parameters, clinical, pharmacological parameters, and fractures. METHODS: Cross-sectional analysis of CARTaGENE, a population-based survey of 40- to 69-year-old individuals. Individuals with CKD (stage 2, estimated glomerular filtration rate [eGFR] 60-89 ml/min/1.73 m2; stage 3, eGFR 30-59) were compared to non-CKD individuals (eGFR > 90). Fracture status (excluding face, toe, hand, and patella) was identified through a questionnaire at baseline. Calcaneal quantitative ultrasound (QUS) was measured in each participant. RESULTS: A total of 17,608 individuals (656 CKD stage 3; 8227 stage 2; 8725 non-CKD) were included. CKD stage 2 and 3 individuals (mean eGFR 78 and 53 ml/min/1.73 m2) were older and had more diabetes, cardiovascular disease, and hypertension. Fracture status prevalence was 14.9% in CKD stage 3, 10.8% in CKD stage 2, and 9.0% in non-CKD individuals. Fracture status prevalence was similar between CKD and non-CKD individuals when stratified by age or after adjustment for demographic and clinical parameters. QUS stiffness index was associated with fracture status in both CKD stage 3 (standardized odds ratio [sOR] = 1.525 [1.200 to 1.939] per 1 SD decrease), stage 2 (sOR = 1.415 [1.310 to 1.530]), and non-CKD individuals (sOR = 1.477 [1.361 to 1.602]). The associations between blood pressure, antihypertensive, and fracture status followed a U-shape throughout the progression of CKD. CONCLUSIONS: CKD stage 3 was not associated with an increase in fracture status. QUS parameters were similarly associated with fracture status in patients with and without CKD.
引用
- Desbiens LC, Goupil R, Sidibé A, et al. Fracture status in middle-aged individuals with early CKD: cross-sectional analysis of the CARTaGENE survey. Osteoporos Int. 2019. PMID: 30796539. doi:10.1007/s00198-019-04902-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。